InvestorsHub Logo
Followers 5
Posts 859
Boards Moderated 0
Alias Born 09/28/2012

Re: Fred Kadiddlehopper post# 5503

Thursday, 07/12/2018 6:34:33 PM

Thursday, July 12, 2018 6:34:33 PM

Post# of 8547
I checked the 'acceptance' press release for Rituxan Hycela (11/3/16) and it did not have a pdufa either. Approval was around 6/22/17 so I'm guessing SC Hercepting should be approved within 8 months (probably 10 months from the filing.)

I had given up on this and I'm happy Roche finally came around to it. I think that, together with Hycela, it should provide some decent revenue growth in '19 in spite of biosimilars. Then, if Darzalex gets approved, revenue growth should really accelerate in '20.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News